SODIUM PHOSPHATE P 32 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sodium Phosphate P 32, and what generic alternatives are available?
Sodium Phosphate P 32 is a drug marketed by Mallinckrodt and is included in one NDA.
The generic ingredient in SODIUM PHOSPHATE P 32 is sodium phosphate p-32. There are one thousand four hundred and seventy-two drug master file entries for this compound. Additional details are available on the sodium phosphate p-32 profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SODIUM PHOSPHATE P 32?
- What are the global sales for SODIUM PHOSPHATE P 32?
- What is Average Wholesale Price for SODIUM PHOSPHATE P 32?
Summary for SODIUM PHOSPHATE P 32
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 8 |
Clinical Trials: | 177 |
Patent Applications: | 4 |
DailyMed Link: | SODIUM PHOSPHATE P 32 at DailyMed |
Recent Clinical Trials for SODIUM PHOSPHATE P 32
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Quince Therapeutics S.p.A. | Phase 3 |
Biotrial | Phase 3 |
Insel Gruppe AG, University Hospital Bern | Phase 2 |
US Patents and Regulatory Information for SODIUM PHOSPHATE P 32
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mallinckrodt | SODIUM PHOSPHATE P 32 | sodium phosphate p-32 | SOLUTION;INJECTION, ORAL | 011777-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Mallinckrodt | SODIUM PHOSPHATE P 32 | sodium phosphate p-32 | SOLUTION;INJECTION, ORAL | 011777-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |